Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90).
Pierga JY, Jouve M, Asselain B, Livartowski A, Beuzeboc P, Diéras V, Scholl S, Dorval T, Palangié T, Garcia-Giralt E, Pouillart P. Pierga JY, et al. Among authors: asselain b. Br J Cancer. 1998 May;77(9):1474-9. doi: 10.1038/bjc.1998.242. Br J Cancer. 1998. PMID: 9652764 Free PMC article. Clinical Trial.
Neoadjuvant chemotherapy in operable breast cancer.
Scholl SM, Asselain B, Palangie T, Dorval T, Jouve M, Garcia Giralt E, Vilcoq J, Durand JC, Pouillart P. Scholl SM, et al. Among authors: asselain b. Eur J Cancer. 1991;27(12):1668-71. doi: 10.1016/0277-5379(91)90442-g. Eur J Cancer. 1991. PMID: 1782080 Clinical Trial.
Prognostic factors in inflammatory breast cancer and therapeutic implications.
Palangie T, Mosseri V, Mihura J, Campana F, Beuzeboc P, Dorval T, Garcia-Giralt E, Jouve M, Scholl S, Asselain B, et al. Palangie T, et al. Among authors: asselain b. Eur J Cancer. 1994;30A(7):921-7. doi: 10.1016/0959-8049(94)90115-5. Eur J Cancer. 1994. PMID: 7946584 Clinical Trial.
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6.
Scholl SM, Fourquet A, Asselain B, Pierga JY, Vilcoq JR, Durand JC, Dorval T, Palangié T, Jouve M, Beuzeboc P, et al. Scholl SM, et al. Among authors: asselain b. Eur J Cancer. 1994;30A(5):645-52. doi: 10.1016/0959-8049(94)90537-1. Eur J Cancer. 1994. PMID: 8080680 Clinical Trial.
Breast tumour response to primary chemotherapy predicts local and distant control as well as survival.
Scholl SM, Pierga JY, Asselain B, Beuzeboc P, Dorval T, Garcia-Giralt E, Jouve M, Palangié T, Remvikos Y, Durand JC, et al. Scholl SM, et al. Among authors: asselain b. Eur J Cancer. 1995 Nov;31A(12):1969-75. doi: 10.1016/0959-8049(95)00454-8. Eur J Cancer. 1995. PMID: 8562150 Clinical Trial.
The purpose of the present paper was to evaluate correlations between clinical response to chemotherapy and outcome in a subgroup analysis of premenopausal patients with tumours considered too large for breast conserving surgery, treated with primary chemotherapy (n = 200) from a …
The purpose of the present paper was to evaluate correlations between clinical response to chemotherapy and outcome in a subgroup analysis o …
Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
Fizazi K, Asselain B, Vincent-Salomon A, Jouve M, Dieras V, Palangie T, Beuzeboc P, Dorval T, Pouillart P. Fizazi K, et al. Among authors: asselain b. Cancer. 1996 Apr 1;77(7):1315-23. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4. Cancer. 1996. PMID: 8608509 Clinical Trial.
384 results